VCYT
Veracyte, Inc.
NASDAQ · USHealthcareBiotechnology
$57.26-3.16%
Price as of Jul 20, 2026
VCYT capital
Veracyte, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.17x
- Debt / assets
- 0.03x
- Debt / EBITDA
- 0.35x
- Net debt / EBITDA
- -1.99x
Liquidity & coverage
- Current ratio
- 9.31x
- Quick ratio
- 8.92x
- Cash ratio
- 7.82x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $466.1M
Cash & dividend
- FCF / debt
- 3.94x
- Cash flow / debt
- 4.22x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.